Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR35 | Q9HC97 | 8/20 | 0.57 |
| ▸ | TTR | P02766 | 2/20 | 0.53 |
| ▸ | MAPT | P10636 | 4/20 | 0.51 |
| ▸ | MEN1 | O00255 | 2/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.51 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.51 |
| ▸ | LMNA | P02545 | 2/20 | 0.51 |
| ▸ | HTT | P42858 | 1/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.47 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.47 |
| ▸ | RECQL | P46063 | 1/20 | 0.47 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.47 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Niclofolan SCHEMBL29385615 | 1.00 | GPR35 (0.57) | GPR35TTRMAPTMEN1KMT2A | |
| SCHEMBL6010796 | 0.89 | GPR35 (0.63) | GPR35TTRMAPTMEN1KMT2A | |
| SCHEMBL4172077 | 0.83 | TTR (0.67) | GPR35TTRMAPTMEN1KMT2A | |
| SCHEMBL310420 | 0.83 | GPR35 (0.69) | GPR35TTRMAPTMEN1KMT2A | |
| SCHEMBL11306670 | 0.82 | TTR (0.57) | GPR35TTRMAPTMEN1KMT2A | |
| SCHEMBL5110264 | 0.81 | AKR1C4 (0.56) | GPR35TTRMAPTMEN1KMT2A | |
| SCHEMBL2404933 | 0.81 | TTR (0.48) | GPR35TTRMAPTMEN1KMT2A | |
| SCHEMBL28045327 | 0.80 | GPR35 (0.53) | GPR35TTRMAPTMEN1KMT2A | |
| SCHEMBL18304977 | 0.80 | TTR (0.54) | GPR35TTRMAPTMEN1KMT2A | |
| SCHEMBL1248770 | 0.80 | GPR35 (0.65) | GPR35TTRMAPTMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1028 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3632656-B1 | IMAGE DATA PROCESSING METHOD FOR PRINTING TECHNOLOGY AND PRINTING SYSTEM | ZHUHAI SAILNER 3D TECH CO LTD (CN) | 2025-08-06 | — | — | EP | claimed |
| EP-4586826-A1 | FEED AND METHODS FOR CONTROLLING HEARTWORM INFECTIONS IN A MAMMAL | In the Bowl Animal Health, Inc. (US) | 2025-07-23 | — | — | EP | claimed |
| WO-2024059837-A1 | FEED AND METHODS FOR CONTROLLING HEARTWORM INFECTIONS IN A MAMMAL | IN THE BOWL ANIMAL HEALTH, INC. (US) | 2024-03-21 | — | — | WO | claimed |
| CN-115957192-A | Preparation method of nitrochlorophenol tablet and nitrochlorophenol compound tablet | 成都乾坤动物药业股份有限公司 | 2023-04-14 | — | — | CN | claimed |
| US-20210128690-A1 | METHODS OF ADMINISTERING HEPCIDIN | LA JOLLA PHARMACEUTICAL COMPANY | 2021-05-06 | — | — | US | claimed |
| EP-3558343-A1 | METHODS OF ADMINISTERING HEPCIDIN | La Jolla Pharmaceutical Company (US) | 2019-10-30 | — | — | EP | claimed |
| CN-110312521-A | Method of administering hepcidin | 拉卓拉药物公司 | 2019-10-08 | — | — | CN | claimed |
| EP-3078664-B1 | ANTIPARASITIC DIHYDROAZOLE COMPOSITIONS | MERIAL INC (US) | 2019-02-20 | — | — | EP | claimed |
| WO-2018118979-A1 | METHODS OF ADMINISTERING HEPCIDIN | LA JOLLA PHARMACEUTICAL COMPANY (US) | 2018-06-28 | — | — | WO | claimed |
| US-9016221-B2 | Surface topographies for non-toxic bioadhesion control | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2015-04-28 | — | — | US | claimed |
| WO-2007061529-A1 | LYOPHILIZATION PROCESS AND PRODUCTS OBTAINED THEREBY | SCIDOSE LLC. (US) | 2007-05-31 | — | — | WO | claimed |
| US-20070116729-A1 | Lyophilization process and products obtained thereby | SCIDOSE LLC | 2007-05-24 | — | — | US | claimed |
| WO-2004006906-A2 | METHODS FOR THE TREATMENT OF NEOPLASMS | COMBINATORX, INCORPORATED (US) | 2004-01-22 | — | — | WO | claimed |
| EP-0710105-A4 | SYNERGISTIC ANTHELMINTIC COMPOSITIONS | UNIV AUSTRALIAN (AU) | 1998-06-10 | — | — | EP | claimed |
| EP-0710105-A1 | SYNERGISTIC ANTHELMINTIC COMPOSITIONS | THE AUSTRALIAN NATIONAL UNIVERSITY (AU) | 1996-05-08 | — | — | EP | claimed |
| WO-1994028887-A1 | SYNERGISTIC ANTHELMINTIC COMPOSITIONS | THE AUSTRALIAN NATIONAL UNIVERSITY (AU) | 1994-12-22 | — | — | WO | claimed |
| US-4957494-A | Multi-layer delivery system | ALZA CORPORATION (US) | 1990-09-18 | — | — | US | claimed |
| US-4874388-A | Multi-layer delivery system | ALZA CORPORATION (US) | 1989-10-17 | — | — | US | claimed |
| EP-0046270-A1 | Novel derivatives of bio-affecting phenolic compounds and pharmaceutical composition containing them | INTERx RESEARCH CORPORATION (US) | 1982-02-24 | — | — | EP | claimed |
| US-4096262-A | VETERINARY MEDICINE | BAYER AKTIENGESELLSCHAFT (DT) | 1978-06-20 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210128690-A1 | METHODS OF ADMINISTERING HEPCIDIN | HAMP, FTH1, HDGF | GPR35 3790/4885TTR 432/4885MAPT 4820/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.